| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000019825 |
| Receipt No. | R000022865 |
| Official scientific title of the study | Effect of preoperative oral rehydration solutions before cesarean section on ultrasound assessment of gastric volume and intraoperative hemodynamic changes |
| Date of disclosure of the study information | 2015/11/17 |
| Last modified on | 2018/05/20 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | Effect of preoperative oral rehydration solutions before cesarean section on ultrasound assessment of gastric volume and intraoperative hemodynamic changes | |
| Title of the study (Brief title) | Effect of preoperative oral rehydration solutions before cesarean section on ultrasound assessment of gastric volume and intraoperative hemodynamic changes | |
| Region |
|
|
| Condition | |||
| Condition | patients undergoing cesarean section | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To compare the gastric content, total intraoperative consumption of vasopressor agent, umbilical blood gas between patients control group and receiving oral fluid going to sleep and 2hours before cesarean section. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | 1.Total consumption of vasopressor agent
|
| Key secondary outcomes | 1.Stomach contents measuring by abdominal ultrasound
2. Electrolytes and blood glucose before anesthesia 3.Intraoperative blood pressure, heart rate, blood loss and duration of surgery 4.Umbical code blood gas analysis |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -but assessor(s) are blinded |
| Control | Active |
| Stratification | YES |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 3 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | Oral intake of food and fluid are stopped after the evening of the day before cesarean section. Administering 6% hydroxyethyl starch (HES) that contains a normal saline solution as an initial infusion after inserting the peripheral venous catheter at the operation room. A total infusion volume of HES is 1000ml. | ||
| Interventions/Control_2 | Oral intake of food is stopped after the evening of the day before cesarean section. Oral intake of fluid is also stopped 2hours prior to the cesarean section. Patients in OS-1 group intake OS-1 500ml before going to sleep and before 2hours prior to the scheduled operation time.
Administering 6% hydroxyethyl starch (HES) that contains a normal saline solution as an initial infusion after inserting the peripheral venous catheter at the operation room. A total infusion volume of HES is 1000ml. |
||
| Interventions/Control_3 | Oral intake of food is stopped after the evening of the day before cesarean section. Oral intake of fluid is also stopped 2hours prior to the cesarean section. Patients in mineral water group intake mineral water 500ml before going to sleep and before 2hours prior to the scheduled operation time.
Administering 6% hydroxyethyl starch (HES) that contains a normal saline solution as an initial infusion after inserting the peripheral venous catheter at the operation room. A total infusion volume of HES is 1000ml. |
||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | Patients undergoing elective cesarean section under CSEA
Informed consent was obtained from all patients. |
|||
| Key exclusion criteria | 1.Emergency Sesarean section
2.Scheduled for cesarean section under general anesthesia 3.With multiple fetus 4.Abnprmal pregnancy(Placenta previa,Placenta accrete and so on) 5.Complications of pregnancy(PIH,GDM,bleeding disorders and coagulopathy and so on) 6.Fetal anomalies 7.Patient who could not be undergo epidural anesthesia 8.The case that anesthesiologist judge inappropriate |
|||
| Target sample size | 45 | |||
| Research contact person | |
| Name of lead principal investigator | Tomoki Sasakawa |
| Organization | Asahikawa Medical University |
| Division name | Department of Anesthesiology and Critical Care Medicine |
| Address | 2-1-1-1 Midorigaokahigashi , Asahikawa, Hokkaido, Japan |
| TEL | 0166-68-2583 |
| sasakawa@asahikawa-med.ac.jp | |
| Public contact | |
| Name of contact person | Tomoki Sasakawa |
| Organization | Asahikawa Medical University |
| Division name | Department of Anesthesiology and Critical Care Medicine |
| Address | 2-1-1-1 Midorigaokahigashi , Asahikawa, Hokkaido, Japan |
| TEL | 0166-68-2583 |
| Homepage URL | |
| sasakawa@asahikawa-med.ac.jp | |
| Sponsor | |
| Institute | Asahikawa Medical University
Kushiro Red Cross Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Asahikawa Medical University
Kushiro Red Cross Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 釧路赤十字病院(北海道) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000022865 |